Tempe, AZ, April 28, 2015 – Statistics & Data Corporation (SDC), a specialized biostatistics and clinical data management Contract Research Organization (CRO), and PRC Clinical, a Clinical Trial Management Expert CRO based in the Silicon Valley, are pleased to announce they have formalized their partnership by signing a Strategic Alliance Agreement.
SDC and PRC Clinical have partnered to provide full-service offerings on various clinical trials over the past 4 years. During this time, the companies have built a collaborative partnership that transcends a typical CRO-vendor relationship. “We have had a great relationship in place with PRC Clinical since 2011. Now that we have successfully supported multiple clinical trials for our shared clients, our management teams believe that this Strategic Alliance Agreement is the final step in formalizing our partnered approach,” said Jim Townsend, Vice President of Business Development at SDC.
“The PRC Clinical team is excited to formalize our solid and long-standing partnership with SDC” states Curtis Head, CEO at PRC Clinical. “We will further leverage our combined expertise and abilities on projects in the United States and beyond”. Earlier this year, PRC Clinical and SDC travelled to Israel to exhibit at the inaugural Outsourcing in Clinical Trials Conference in Tel-Aviv, and aim to support Israeli sponsors targeting to the US market.
Highlights of SDC and PRC Clinical’s Strategic Alliance include:
Simplified outsourcing process for full-service projects
No vendor management hassle for clients – one seamless, expert project team under one contract
Efficient processes and familiar study teams following years of collaboration
Shared culture of providing personalized services and superior customer service to clients
With the relationship formalized and the Strategic Alliance Agreement in place, SDC and PRC Clinical plan to continue supporting clinical trials as a seamless full-service CRO solution.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.